kong – 第 8 页

ACN Newswire

Jacobson Pharma Announces FY2023 Interim Results

25 11 月, 2022

HONG KONG, Nov 25, 2022 - (ACN Newswire via SEAPRWire.com) - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2022 (the "Reporting Period").KEY HIGHLIGHTS-- Revenue grew by 8.9% period-on-period, totaled HK$817.4 million-- Profit for the period up by 77.8%, amounted to HK$147.4 million -- Profit attributable to equity shareholders up by 70.2%, amounted to HK$136.2 million-- Sound financial position with net gearing ratio decreased from 29.2% to 20.8% -- The Board declares an interim dividend of HK2.8 cents per share-- Promising sales growth witnessed on certain key therapeutic lines including cardio-vascular, anti-diabetic as well as cold and flu products.-- Arsenic Trioxide Oral Solution, being the first specialty medicine made in the Group's PIC/S GMP plant alongside robust clinical substantiation, attained approval for use in designated hospitals in the Greater Bay AreaDuring the Reporting Period, the Group delivered total revenue of HK$817.4 million, which represented a period-on-period growth of 8.9%. Gross profit increased by 24.8% to HK$340.4 million, whilst profit attributable to equity shareholders amounted to HK$136.2 million, up by 70.2%, which was mainly attributed to the uplifted sales revenue, alongside the enhancement in product mix and operating leverage, coupled with the subsidies from the HKSAR Government pertinent to the Employment Support Scheme.The Group maintains a healthy financial position as supported by its strong cash flows, with adjusted EBITDA of HK$290.5 million for the Reporting Period and the net gearing ratio decreased significantly from 29.2% as at 31 March 2022 to 20.8% as at the end of the Reporting Period. In addition, the Group has a sound cash position, with cash and cash equivalents of HK$860.4 million as at the end of the Reporting Period. The Board declares the payment of an interim dividend for the six months ended 30 September 2022 of HK2.8 cents per share, up by 133.3% as compared to HK1.2 cents of FY2022 Interim.Robust Portfolio of Essential Medicines to Meet Healthcare DemandDuring the reported period, the generic drugs business of the Group demonstrated resilient performance, driven by steady growth in both private and public sectors. Overall growth was benefitted from the easing of social distancing measures which facilitated the resumption of medical consultation visits in both public and private sectors in Hong Kong, thus boosting the demand for essential drugs as well as specialty medicines.Amid the fifth wave of the epidemic outbreak, the Group geared up its production and supply of symptomatic relief medicines to cater for the increased public demand, which was reflected by the growth of 48.5% in the Group's range of cold and flu preparations in the public sector for the Reporting Period.In addition, exhibiting a robust trend, medications for the aging population and chronic disease patients continued to present a strong demand. A case in point was that angiotensin II receptor antagonists and lipid-lowering products in the cardiovascular product class recorded a strong growth of 66.4% and 60.0% respectively in the private sector during the Reporting Period.Steady Product Pipeline and Continuous Efforts in Portfolio EnhancementAs a continuous effort to meet the medical and patient needs with quality essential medicines, the Group launched a number of new products including Atorvastatin Tablet, Trimetazidine Modified Release Tablet, Olmesartan Tablets, Bicalutamide Tablet, Ofloxacin Ear Drop and Idarubicin Injection during the Reporting Period. Additionally, the Group has secured registration approval for 21 new products for upcoming market launches.As of 30 September 2022, the Group has a total of 177 products in its research and development pipeline, among which 59 items have been approved for registration, 14 of them have been submitted for registration, 48 items have finished the development stage and are under stability preparation or stability study, and 27 items currently under formulation or pre-formulation research development stage.Making In-roads into the Greater Bay AreaThe Group's collaboration with the University of Hong Kong-Shenzhen Hospital in introducing its oral solution treatment for acute promyelocytic leukemia, Arsenic Trioxide Oral Solution, into designated hospitals in the Greater Bay Area has been given approval by Guangdong Province Medical Product Administration. This marked the first Hong Kong-made specialty medicine ever gained approval under the "Interim Regulations on the Administration for Importing Urgently Needed Clinical Drugs and Medical Devices from Hong Kong and Macao to the Guangdong-Hong Kong-Macao Greater Bay Area of Guangdong Province".Formulation of ESG Strategy and Respective KPIsAs a corporate citizen that places long-term commitment to environmental, social and governance ("ESG") duties, Jacobson Pharma has formulated and progressed on its ESG strategy, "Jacobson 5 to Thrive", which underpins five priority areas, namely, product responsibility, commitment to employees, environmental stewardship, societal engagement and corporate governance duty. In response to such strategy, key performance indicators (KPIs) have been set and will continue to be evaluated from time to time in order to track respective progress on priority issues and programs, including greenhouse gas emissions, water and electricity usage, as well as utilisation of renewable energy.Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma, noted, "Although COVID-19 has had an impact on the Group's business performance, we believe it will be transient. We are delighted that Jacobson Pharma achieved notable growth momentum in the first half of FY2023 amid the volatile economic sentiment. Thanks to the concerted effort of our teams, we delivered a resilient performance across both private and public sectors for our core business demonstrating an enhanced operational efficiency and a disciplined cost control. "We remain positive about the future outlook of the healthcare industry and the growth prospect of the market for essential medicines. To capitalise on the emerging opportunities, we will continue to focus on advancing the Group's growth strategies and positioning it as an eminent provider of essential medicines and specialty drugs in Hong Kong and the Greater Bay Area."About Jacobson Pharma Corporation Limited (Stock Code: 2633)Jacobson Pharma is a leading pharmaceutical company in Hong Kong vertically integrated and engaged in the research, development, production, sale and distribution of essential medicines and specialty drugs. As a major provider of generic drugs in Hong Kong, the Group has one of the most extensive sales and distribution coverage for both the private and public sectors in Hong Kong, with an expanding reach into strategically selected Asian markets. Carrying a broad product portfolio and taking a pre-eminent market position in a number of therapeutic categories, the Group operates a host of 10 PIC/S GMP licensed production facilities for generic drugs in Hong Kong.The Group aims at the continued strategic enrichment of its generic drug portfolios through the addition of high-value-added products. With its corporate headquarters based in Hong Kong, the Group has also established its operating subsidiaries in China, Macau, Taiwan and Cambodia, forming a regional commercial platform to tap the market potential in the Asia Pacific and Greater China region. Jacobson Pharma has been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June 2017. For more details about Jacobson Pharma, please visit the Group's website: http://www.jacobsonpharma.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

ACN Newswire

中国万天控股完成收购国内生鲜供应链服务商

25 11 月, 2022

HONG KONG, Nov 25, 2022 - (亚太商讯 via SEAPRWire.com) - 中国万天控股有限公司（「中国万天控股」，连同其附属公司统称「集团」；股份代号：1854.HK）欣然宣布，集团的直接全资附属公司富源有限公司（「富源」）完成收购冠源有限公司（「冠源」）旗下于国内从事生鲜供应链服务商深圳丰源贸易发展有限公司（「深圳丰源」，连同冠源，统称「目标集团」），标志着集团将食物供应业务扩展至粤港澳大湾区（「大湾区」）市场。收购完成后，目标集团成为集团的全资附属公司。是次集团收购的目标集团主要在中国从事活牛、水果、蔬菜、海鲜及食材的贸易。深圳丰源是目标集团的营运附属公司，其主要业务为从内蒙古获得活牛，并将活牛分配予大湾区的屠宰场，同时向大湾区的餐厅供应及提供水果、蔬菜及海鲜。深圳丰源在中国拥有成熟的业务网络和客户基础，有助集团为客户提供全面的服务组合和扩阔客户基础。在2019冠状病毒病爆发对香港餐饮及相应食品加工行业带来不利影响之际，集团管理层相信进军新市场和提升业务发展策略的多元性有利于保持竞争力，为投资者和股东创造更高收益。除收购目标集团外，集团亦于近日在广东省中山市人流畅旺的中心地带策略性增设两间餐厅，分别为主打生鲜食材的蒸气海鲜专门店「争气码头」和将空间与自然结合的咖啡厅「空想咖啡」，锐意扩大集团于大湾区的餐厅网络，壮大食物供应和餐饮连锁业务。「争气码头」和「空想咖啡」均以年轻消费者为主要客户群，配合「个性化需求」、「沉浸式体验」和「打卡」等潮流概念为追求生活质量、食得健康的年轻食客而设。主打蒸气海鲜的「争气码头」可让食客赏尽天下不同种类的鲜活海鲜，为食客提供最新鲜的菜肴；而走清新路线的「空想咖啡」融合空间与艺术，不时有现场表演，让食客在享受精致菜色及优美环境的同时，还可满足在咖啡厅扩展社交朋友圈的需求。受惠于政府出台的「中山市2022年促进批发零售住宿餐饮行业稳增长措施」等一系列带动地区经济与民生指数的政策，2022年前三季度中山市生产总值为人民币2,594.81亿元，同比增长1.2%。中山市消费市场恢复良好，前三季度全市社会消费品零售总额为人民币1,208.91亿元，同比增长5.1%。秉持着对中山市未来庞大发展潜力的信心，集团今次战略性地开设两家餐厅，这亦是继集团于今年6月在中山市开设两间餐厅「香港码头」和「炙.HUTAU」后，短时间内再在区内扩大「万天餐饮」业务版图。集团管理层表示，集团成功收购深圳丰源，以及于策略性在中山市增设两间餐厅后，均彰显集团加大力度发展食物供应和餐饮连锁业务的决心和积极部署。身处后疫情时代，集团将进一步拓展现有业务至具庞大消费群的大湾区市场，并善用食物供应、餐饮产业链和环保科技三大业务之间的协同效应，以应对挑战，奠定强大基础。展望未来，中国万天控股锐意扩展业务以提升业务发展策略的多元性，而大湾区业务将是集团最大的盈利增长点，长远可望为集团带来稳定持续的收入。关于中国万天控股有限公司中国万天控股有限公司（1854.HK）为一间投资控股有限公司，集团主要从事食材供应、餐饮连锁和环保科技三大重点业务。2022年5月，中国万天控股在深圳设立大湾区总部，标志着集团正式进军潜力庞大的大湾区市场，积极打造大湾区绿色龙头品牌，为客户提供新鲜健康及安全的食品，致力成为中国领先的美好生活服务商。有关更多资料，请浏览：chinawantian.etnet.com.hk Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

ACN Newswire

The Hong Kong Institute of Directors Holds Silver Jubilee Dinner and Presentation Ceremony for Directors Of The Year Awards 2022

25 11 月, 2022

HONG KONG, Nov 25, 2022 - (ACN Newswire via SEAPRWire.com) - The Hong Kong Institute of Directors ("HKIoD") has announced the winners of the Directors Of The Year Awards ("DYA") 2022. As the flagship project of HKIoD, DYA is one of the most prestigious business accolades in Hong Kong and the first of its kind in Asia. It seeks to recognise outstanding boards and directors, publicise the significance of good corporate governance and promote good corporate governance and director professionalism. The Awards were presented during the Silver Jubilee Dinner that celebrates the 25th Anniversary of both HKSAR and HKIoD, both having operated since 1 July 1997.Financial Services and the Treasury (6th from the left, 1st row) bestows on the long-term loyal members of HKIoD souvenirs in recognition as Silver Jubilee Stars. They joined the membership in 1997, the inception year of HKIoD.Congratulations to the awardees, who are inspiring role models for all directors!This year's theme of work by HKIoD, notably in the Awards, is 'From Resilience to Sustainability', reflective of what directors have learnt over the years as resilience is the most important quality a company needs to survive in the ever-changing world and sustainability is the ultimate goal of every company.The winners have been recognised for their ability to cultivate resilience in their businesses to the degree that they are able to anticipate, prepare for and respond to incremental change in an age of great disruption, whilst setting the pace for excellent sustainability-focused leadership now and into the future. The winners of DYA 2022 in the various award categories are listed below: Listed Companies CategoriesExecutive Directors-- Mr TAI Chun KitFour Seas Group-- Ms TANG Mei Wah Town Ray Holdings Limited Boards-- Baguio Green Group Limited -- China Resources Beer (Holdings) Company Limited -- Tai Hing Holdings Group LtdNon-listed Companies CategoriesExecutive Directors-- Ms LINShun Heung, Ophelia Meiriki Japan Company Limited Boards-- Hong Yip Holdings LtdStatutory/Non-Profit Distributing Organisations CategoriesExecutive Directors-- Ms LI Sum, Helen The Institute of Internal Auditors Hong Kong Limited Non-Executive Directors-- Ms Cordelia CHUNGHong Kong Science and Technology Parks Corporation -- Mr Dennis HOChiu PingHong Kong Science and Technology Parks Corporation -- Mr Andrew JONES Kely Support Group Boards-- Competition Commission -- Board of Consumer Council -- General Committee of Federation of Hong Kong Industries -- Hong Kong Science and Technology Parks Corporation About Directors Of The Year AwardsThe Hong Kong Institute of Directors ("HKIoD") is Hong Kong's premier body representing directors to foster the long-term success of companies through advocacy and standards-setting in corporate governance and professional development for directors. A non-profit-distributing organisation with membership consisting of directors from listed and non-listed companies, HKIoD is committed to providing directors with educational programmes and information service and establishing an influential voice in representing directors. With international perspectives and a multi-cultural environment, HKIoD conducts business in biliteracy and trilingualism. HKIoD is a member institute of the Global Network of Director Institutes, a worldwide alliance of leading director institutes.About The Hong Kong Institute of DirectorsThe Hong Kong Institute of Directors is Hong Kong's premier body representing directors to foster the long-term success of companies through advocacy and standards-setting in corporate governance and professional development for directors. A non-profit-distributing organisation with membership consisting of directors from listed and non-listed companies, HKIoD is committed to providing directors with educational programmes and information service and establishing an influential voice in representing directors. With international perspectives and a multi-cultural environment, HKIoD conducts business in biliteracy and trilingualism. Website: http://www.hkiod.com.Media Enquiries:Strategic Public Relations Group LimitedBrenda Chan +852 2114 4396/ brenda.chan@sprg.com.hkChak Yau +852 2114 4395/ chak.yau@sprg.com.hkDirectors Of The Year Awards:The Hong Kong Institute of Directors Odessa So +852 2889 4988 / odessa.so@hkiod.comJoanne Yam +852 2889 1414/ joanne.yam@hkiod.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

ACN Newswire

穆迪：确认渤海银行“Baa3”长期存款评级展望维持稳定

25 11 月, 2022

HONG KONG, Nov 25, 2022 - (亚太商讯 via SEAPRWire.com) - 据香港万得通讯社报道，近日，享誉全球的国际权威评级机构——穆迪投资者服务公司（Moody’s Investors Service，以下简称“穆迪”）发布报告，确认渤海银行股份有限公司（以下简称“渤海银行”）（9668.HK）Baa3的长期存款评级，同时维持渤海银行主体信用评级为投资级评级，展望稳定。市场人士评价指出，这一评级结果显示出国际主流评级机构对渤海银行经营发展情况的认可，将有助于提振投资人信心，为渤海银行在国际资本市场提高议价能力及降低融资成本奠定良好的基础。流动性状况稳定适中系统重要性日益凸显信用是金融交易得以产生的原动力与核心基础。作为提供金融交易主体履约能力或偿付能力评判主体的信用评级机构，其出具的资信报告、风险提示成为越来越多金融交易、投资决策乃至监管部门的判断基础风险的重要依据。穆迪在此次发布的报告中指出：此次维持渤海银行的评级和稳定展望，反映了穆迪预期未来12-18个月，该行的财务状况将总体保持稳定，并且同期中国政府对该行提供支持的意愿和能力将基本维持不变。同时维持渤海银行主体信用评级为投资级评级，展望稳定。尽管国内外疫情持续对业务开展产生部分影响，但渤海银行近年来为减少对高风险行业的贷款敞口和对影子银行产品的投资敞口，采取了多种降风险举措，这也表明该行战略重点从规模扩张转向高质量发展。穆迪预计，未来12-18个月，渤海银行的流动性状况将维持在稳定的适中水平，核心一级资本充足率仍将维持在8.0%-9.0%以上。此外，穆迪还在报告中指出，渤海银行的系统重要性在多方面日益得到凸显：从成立背景来看，该行是在天津成立的唯一一家全国性股份制商业银行，具有强大的政府持股背景，其中各类央企和天津政府下属实体持股50.45%。从战略地位来看，作为天津市最大的国有金融机构，渤海银行是政府进一步发展和加强天津市金融服务业规划下的旗舰企业。因此，渤海银行的存款评级、交易对手风险评级和交易对手风险评估有3个子级的提升，分别达到Baa3、Baa3和Baa3（cr）。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

ACN Newswire

粤港澳大湾区美业（产业）青年双创研讨会暨CIBE中国国际美博会战略合作签约仪式

24 11 月, 2022

HONG KONG, Nov 24, 2022 - (亚太商讯 via SEAPRWire.com) - 粤港澳大湾区美业（产业）青年双创研讨会暨CIBE中国国际美博会战略合作签约仪式在广州在线会场和香港线下会场同时举行，活动通过粤港澳青年企业家、美妆行业专家、电商界巨头等多方研讨，推进大湾区美妆行业产学研的深度融合，加快推进港澳和内地之间产业及人才的融合发展，将国内美妆产业推向国际舞台，进一步赋能美妆行业。本次活动由广州市人民政府港澳事务办公室、广州市番禺海外联谊会、广州市番禺区科工商信局、广州大学城管委会、共青团广州市番禺区委员会共同指导，粤港澳青年创业孵化器、卓悦控股有限公司、香港猫、香港产业创新中心、CIBE中国国际美博会联合主办。活动以粤港澳青年创业孵化器广州大学城会场与卓悦控股有限公司香港会场在线联机互动的形式进行，特别邀请番禺区委常委、广州市番禺海外联谊会理事长邓耀棋、香港特区政府商务及经济发展局副局长陈百里、中国国家行政学院（香港）工商专业同学会（CAGA）会长、粤港澳青年创业孵化器荣誉主席、香港保良局总理、太平绅士陈健文共同为活动致辞，邀请两地相关政府机构代表、高校科研机构代表、粤港澳美妆行业专家及粤港澳台侨青年等多方代表嘉宾参与。为了打造粤港澳大湾区美妆集聚平台，引领穗港两地美妆行业青年双创的发展，打造国际知名美妆产业与人才集聚地标，粤港澳青年创业孵化器携手CIBE中国国际美博会共同签署战略合作协议，成立粤港澳大湾区美业（产业）青年双创基地，未来将深度整合上中下游产业链资源，涵盖上游的品牌商、供应链，中游的MCN机构、服务商，实现美妆行业产学研创投的深度融合。 CIBE中国国际美博会副总裁黄寅许、粤港澳青年创业孵化器总经理王寒发表了对合作平台的展望，未来将共建美妆行业青年双创人才培育实践体系，依托香港卓悦丰富的产业资源、广州大学城得天独厚的青年人才聚集优势，立足湾区，辐射全球，通过开展美妆行业产学研资深度链接，整合大湾区优质产业资源，汇聚粤港澳优秀产业资本，实现地区产业升级驱动，人力资源价值挖掘，赋能美妆产业，共同推动粤港澳大湾区经济发展。在香港猫平台以及校园猫盒启动仪式上，香港猫总裁苏婕介绍了香港猫平台以及校园猫盒项目，作为香港电商香港购物平台，香港猫触达34个国家，共销售往44个中国内地及海外渠道平台，提供多元化种类产品，迎合不同阶层的市场顾客需求。随后，珠海市煜晟电子商务有限公司总经理李泽杭作为校园猫盒校园推广者录制视频分享校园猫盒项目的发展前景。在研讨会上，香港化妆品同业协会监事长及执行顾问何绍忠、香港零售科技商会主席苏增慰、华润资本董事总经理蔡达盟以“美颜产业与资本的创新互动，资本如何助力产业转型”为主题进行分享，从“资本如何看美颜产业发展”、“资本如何助力美颜产业从业者转型”两个角度发表了各自的见解。随后，电商行业专家eBay业务发展经理黄竣霆、区锦明、阿里云香港、澳门地区及菲律宾数据智能解决方案主管林绍文、Key Account Manager, Google Customer Solutions Grace Ng 就“科创企业与平台，新的美颜趋势下，如何助力产业创新”主题，从多角度、多层面深入探讨平台上呈现的美颜消费趋势以及助力商家产业创新的举措。本次活动圆满结束，未来，粤港澳大湾区美业（产业）青年双创基地将基于各方优质资源，共同推进粤港澳大湾区青年美业双创人才融合发展，发挥引才、招才、留才、用才的优势，加速人才融入湾区、共建湾区、共享湾区进程，推动形成新时代全面开放新格局，努力开创粤港澳大湾区美业创新创业新局面。关于卓悦控股有限公司卓悦控股有限公司（股份代号：653.HK）建基于「Beauty, Health & Beautiful Life」的全新概念，自2020年开始积极推动以「科技+消费」为基础的新业务模式。在数字化新零售应用科技的支持下﹐集团的香港猫(HKMALL) 香港购物平台能已达34个国家，共销售往44个中国内地及海外渠道平台，包括天猫国际、考拉、京东、Facebook、YouTube、Instagram、海淘网及微信商城等平台。除了自身发展，集团亦致力为中小企商户提供最优质的电子商务服务及全方位智慧零售解决方案，助力企业脱变。集团创立「香港产业创新中心」为初创企业提供孵化培育服务，加速企业成长。卓悦现于香港及澳门共设有10间线下零售店，并自设KOL直播间，培育200名销售人员直播销售，在9个直播平台带货。传媒查询：意博资本文化有限公司吴霆远 Terence Ng 3890 7512 欧阳丽珠 Doris Au Yeung 3890 7513 任振悦子 Sherry Ren 3890 7514 电邮：ir_bonjour@vsfg.com Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

阳光保险通过港交所聆讯：多战略并举高质量发展

24 11 月, 2022

HONG KONG, Nov 24, 2022 - (亚太商讯 via SEAPRWire.com) - 香港市场有望新添一枚稀缺保险标的。11月21日，港交所文件显示，阳光保险集团股份有限公司（“阳光保险”）通过聆讯，赴港上市进入冲刺阶段。若阳光保险成功登陆港交所，将成为中国第10家上市险企，也将成为继中国人保、中国平安、中国太保、中国太平、中再保险集团之后的第六家上市保险集团公司。在中国的众多险企中，阳光保险是一隻快速成长的新生力量，公司以“打造高质量发展、高价值成长的保险服务集团”为战略目标，多战略并重推进，致力于成为专业领先的家庭保险保障服务提供商与值得信赖的企业风险管理伙伴。从客户价值创造出发分类实施客户经营战略在客户经营方面，阳光保险根据客户群体性质，对个人客户及团体客户分别实施针对性的发展战略，客户经营水平持续提升。个人客户方面，阳光保险基于不同的家庭类型以及不同家庭阶段个人需求的不同，为客户提供优质差异化的综合保险服务，实现客户有效需求与保险公司有效供给的匹配，从而为客户和公司自身创造价值。团体客户方面，公司聚焦价值创造，深耕价值客户，坚持价值发展，不断改善团体客户的风险管理能力，努力成为团体客户一揽子风险管理服务的忠诚伙伴。凭借对客户的洞察能力，阳光保险能够更好地识别不同客户购买需求偏好，从而能够提供更加适配需求的产品及服务，赋能销售队伍，促进业务增长。通过多年发展，公司客群经营有效夯实，客户群体逐步增多，截至2022年6月30日，拥有约3,150万名个人客户和约80万家团体客户。加强渠道专业化建设以渠道成长赋能企业成长保险行业转型趋势下，渠道的核心价值决定了企业的竞争优势。阳光保险通过强化渠道专业化建设，促进传统渠道与新兴渠道融合互补，推动业务高质量发展。寿险代理人渠道上，阳光保险通过实施差异化的经营策略，以匹配当地市场需求。在二线及以上城市，公司主打中高端客群的增值服务项目，通过打造高素质和高产能的队伍，优化队伍专业化服务能力。在三线及以下区域，公司针对大众家庭的增值服务，逐渐丰富保险产品类型。寿险银保渠道上，公司坚持价值发展，实施渠道分类经营，稳步扩大中高优质客群，银保渠道保费收入占比逐年上升。产险业务方面，深耕渠道专业化能力建设，在巩固和强化传统直销渠道的同时，进一步加强新直销渠道建设，推进网销、电销一体化转型，发挥直联客户优势。此外，阳光保险充分发挥集团协同优势，积极培育职域营销和私域营销两大新型营销渠道。在职域营销上，公司通过与团体客户的深度合作，引导团体客户向个人客户转化，深度挖掘客户价值，打开个人高端客户的增长空间。在私域营销上，公司以客户为中心，通过私域客户经营、线上化客户服务，打造从线上获客到运营转化的经营闭环，充分增强盈利能力。长期来看，保险行业正从高速发展向高质量发展转变，阳光保险通过多元化的发展战略，持续提高客户服务质量，增进客户认可度，有助于其把握未来行业转型下的发展机遇，实现“让人们拥有更多的阳光”的使命。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

ACN Newswire

医思健康公布2022/23年度中期业绩医疗服务业务推动收入同比增长31.1%

24 11 月, 2022

HONG KONG, Nov 24, 2022 - (亚太商讯 via SEAPRWire.com) - 香港最大非医院医疗服务机构* ── 医思健康（“公司”，连同附属公司，总称“集团”；香港联交所股份编号：2138）公布截至2022年9月30日止六个月（“期内”）未经审核之中期业绩。业绩摘要-- 集团总收入同比上升31.1%至18.93亿港元-- 集团医疗分部收入同比上升47.5%至11.75亿港元，收入占比提升至62.1%-- 集团美学医疗及美容养生业务分部贡献收入同比减少2.0%至6.07亿港元，收入占比约32.1%-- 在此前收购的兽医业务的推动下，集团来自其他服务分部的收入同比增加301.9%至1.11亿港元，收入占比约5.8%-- 集团内生业务贡献之收入(1)同比上升22.8%至17.74亿港元，占比达93.7%-- 期内集团录得息税折旧及摊销前之盈利（“EBITDA”）2.70亿港元-- 期内集团税后净溢利为1.05亿港元-- 期内每股基本盈利为6.8港仙-- 董事会宣派中期股息每股5.8港仙，派息比率为85.3%，将以现金派发-- 截至2022年9月30日，集团已执行总估值为2.19亿港元的收并购，涵盖多个医学专科服务、兽医及健康检查服务，医疗服务布局得到进一步强化-- 集团医疗服务覆盖的医疗学科及专科数目达35个，全职注册专属医生团队人数增加至293人-- 本集团保持优质的服务质量，客户满意度高达99.98%(6)-- 老客户贡献之收入占集团总收入的71.6%(3,7) -- 客户忠诚度保持高水平，复购率为93.7%(4,7)-- 集团服务点数目扩张至154个，总楼面面积同比增加约24.1%至557,000平方呎期内，集团面临多重挑战，包括全球经济下行、长期旅游限制导致的医疗旅客数目骤减、本地零售市道疲弱及疫情反复带来的业务中断扰动。尽管如此，集团业绩仍维持韧性。得益于对本集团提供医疗服务的强劲需求及多元化经营策略，本集团仍得以增加其于医疗市场的份额，多元化服务范围，并巩固其作为香港最大的非医院医疗服务供应商的领先地位。市场对集团提供的医疗服务维持旺盛需求，集团于期内进一步拓展市场份额并推行有效的销售策略。期内集团录得销售额18.12亿港元，同比增长18.3%；收入同比增长31.1%至18.93亿港元。集团内生业务贡献之收入(1)同比上升22.8%至17.74亿港元，收入占比达93.7%。集团于期内执行的并购交易总估值为2.19亿港元，涵盖多个医学专科服务、兽医及健康检查服务，集团以客户为中心的医疗服务布局得到进一步强化。然而，期内集团税后净溢利同比下跌46.3%至1.05亿港元。净利率承压主要由于疫情反复引致的集团于香港及澳门的美容养生业务遭强制停业，以及在中国内地面临的业务中断。净利率下降8.0个百分点至5.6%。期内，集团面临的市场竞争环境日趋激烈、通胀导致成本结构上升、上一财政年度新设立服务点的营运协同暂时较低，以及新收购医疗资产所产生的折旧及摊销开支的增加亦令集团期内的盈利能力承压。集团投放了资本开支以支持新医疗设施内生增长，但相关设施于报告期内暂未投入服务及产生相应收入。有鉴于此，本公司权益股东应占纯利为80.0百万港元。每股基本盈利为6.8港仙，去年同期则为14.2港仙。多年来，本集团凭借专业团队所提供优质的客户服务，通过闭环生态系统建立了忠实的客户群。期内，集团客户服务个人客户数稳步增加至122,883 (2,7)人，老客户贡献之收入占集团总收入的71.6%(3,7)。客户忠诚度保持高水平，复购率为93.7%(4,7)。集团构建的大健康闭环生态系统发挥协同效益，期内有超过28.1%(5)的客户跨品牌进行消费。同时，本集团保持优质的服务质量，客户满意度高达99.98%(6)。集团服务点数目在内生扩张及收购的推动下有所增加。截至2022年9月30日，集团总共拥有154个服务点，包括134个位于香港，4个位于澳门及16个位于中国内地，总楼面面积同比增加24.1%至约557,000平方呎。较二零二二财年上半年净增加的约108,000平方呎中，约69.1%来自医疗业务，而约22.8%来自美学医疗及美容养生服务业务。集团医疗服务覆盖的医疗学科及专科数目达35个，全职注册专属医生团队人数增加至293人。医疗服务业务快速增长对医疗的刚性需求推动医疗分部继续成为主要的增长动力。集团继续透过内生扩张及并购增长，在大健康市场继续拓展市场份额。集团医疗服务分部的收入同比上升47.5%至11.75亿港元，收入占比提升至62.1%。期内集团的医疗收入中，内生增长及收并购的贡献占比分别为90.8%及9.2%。内生增长主要受到有效的销售策略、客户逐渐提升的医疗保健意识和对应需求的增加所推动。期内，医疗分部已执行总估值为1.75亿港元的收购。美学医疗及美容养生服务分部轻微下滑期内，集团美学医疗及美容养生服务贡献的收入同比减少2.0%至6.07亿港元，占总收入约32.1%。香港部分收入同比轻微下滑5.4%至4.61亿港元，主要由于二零二二年四月份遭强制停业20日，客户被压抑的需求于稍后逐步复苏。内地美学医疗市场面临疫情反复带来的业务中断。期内尽管深圳、广州及上海分别业务中断的平均时长达26日、10日及122日，来自中国内地的收入依然同比增长12.6%至89.8百万港元。期内集团于澳门的美学医疗及美容养生业务平均遭强制停业31日，澳门的收入同比小幅增加7.7%至56.8百万港元。其他分部增长强劲期内，受此前收并购的兽医业务的拉动，其他服务分部的收入同比增加301.9%至1.11亿港元，收入占比达5.8%。医思健康主席、执行董事兼行政总裁邓志辉先生总结：“受益于香港政府迈向‘常态化’的政策立场及逐渐放宽对入境旅客的隔离措施，本地消费情绪逐步提振。但总体市场不景气仍可能令集团旗下业务短期承压。然而，我们相信医疗市场仍然有无限增大潜力，长远而言公私营合作将带动香港私营医疗市场支出不断增加。基于集团高增益的收并购策略，我们将持续提升医疗及美容领域的业务多元化水平，收购对我们核心业务具有互补及增值作用的项目，以建立一站式医疗保健及养生平台，更好地服务客户。同时，我们将继续深化与科技、电讯、保险、房地产及制药行业巨头的战略合作伙伴关系，以建立大健康生态系统。集团不断致力于通过优化企业架构，提升管理能力，在数字化转型的助力下优化资源配置以提升运营效率。集团将持续通过推行持股管理人文化及倡导公仆式领导力，提升人才生产力及对公司的认同感。”关于医思健康香港最大非医院医疗服务供应商*医思健康以预防及精准医疗为业务核心，透过多元服务整合发展医疗人工智慧，配套高端品牌及优质客户服务，致力为客户提供最专业、安全、有效的医疗健康服务。集团为恒生综合指数成份股及MSCI香港小型股指数。集团目前直营的诊所／服务中心主要位于大湾区，提供一站式医疗及健康服务。服务涵盖面极广，旗下主要知名服务品牌包括连续多年荣膺全港第一的一站式医学美容解决方案DR REBORN、专业健发中心发森及多元化多维度的医学服务包括：健康管理中心香港仁和体检中心、疫苗中心香港安苗医疗中心、普通科门诊未来医生、全港最大一站式痛症管理平台纽约脊骨物理治疗中心、全方位牙科服务中心庇利积臣牙科医务所，EC DENTAL CARE及恒健牙科医务所、高端影像中心博思医学诊断中心、仁生肿瘤及癌症中心、内视镜及日间医疗中心仁辉专科中心、专科中心进汇医务中心，联汇专科，新医疗中心、儿科专科汇儿儿科医务中心、妇产科专科卓越医务中心及产前诊断中心、柏立医学化验所、眼科中心唯视眼科和医思兽医医院及影像中心。*根据弗若斯特沙利文公司按2020年及2021年收入计算进行的独立研究注1. 期内总收入减期内新入账之新收购资产贡献收入2. 基于期内的收入3. 老客户于期内收入贡献除以期内总收入4. 年化期内老客户贡献之收入，除二零二二财年总收入5. 于期内消费多于一个品牌服务客户数目除以期内客户总数，基于31个品牌在内的内部系统数据6. 100% 减重大不利反馈占当期总收入的百分比7. 基于39个品牌在内的内部系统数据若有进一步垂询，请联络：iPR奥美公关刘丽恩 / 陆咏诗 / 田野电话：(852) 2136 6952 / 2169 0467 / 3920 7654传真：(852) 3170 6606电邮：ech@iprogilvy.com Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

Perfect Medical Announces Interim Results for FY2022/23

23 11 月, 2022

HONG KONG, Nov 23, 2022 - (ACN Newswire via SEAPRWire.com) - Perfect Medical Health Management Limited (the "Company" , Stock Code: 1830.HK), one of the largest aesthetic medical operators in the world, together with its subsidiaries (collectively referred to as the "Group"), is pleased to announce its interim results for the six months ended 30 September 2022.RESULTS HIGHLIGHTS-- The Group's revenue decreased by 16.6% to HK$668.3 million, impacted by Covid-19 pandemic causing suspension of 20 days in Hong Kong, 39 days in Macau, as well a business disruption for an average of 14 days, 23 days, 63 days and 19 days across Guangzhou, Shenzhen, Shanghai and Beijing respectively.-- The second quarter marked a 52.1% growth in revenue quarter-on-quarter in Hong Kong following the ease of Covid-19 pandemic.-- The Group's EBITDA decreased by 25.5% to HK$229.7 million.-- The Group's net profit decreased by 30.4% to HK$150.7 million, representing the net profit margin of 22.5%. Basic earnings per share was HK12.1 cents.-- The Board recommends the payment of an interim dividend of HK13.0 cents per share, representing a dividend payout ratio of 107.4%.-- The Group operated a total of 307,000 square feet in Hong Kong, China, Australia and Singapore, with an addition of three shops in Hong Kong, Guangzhou and Beijing during the period.For the period under review, the Group's performance has been impacted by the slower consumption trend in Hong Kong and the return of the pandemic in China. The Group's revenue decreased by 16.6% to HK$668.3 million (FY2022 interim: HK$801.6 million). At EBITDA level, the Group decreased by 25.5% to HK$229.7 million (FY2022 interim: HK$308.2 million). During the period, the Group has taken a prudent approach in our business expansion, enhancing operating efficiency, business mobility and adaptability in the forefront to better protect the assets and profitability of the Company. Profit attributable to equity holders of the Company was HK$150.7 million, dropped 30.4% year-on-year (FY2022 interim: HK$216.4 million), representing a net profit margin of 22.5% for the period (FY2022 interim: 27.0%). Basic earnings per share was HK12.1 cents (FY2022 interim: HK17.7 cents).As of September 2022, the Group operated a total of 307,000 square feet in Hong Kong, China and overseas. Hong Kong OperationRevenue from Hong Kong operation decreased by 21.5% to HK$492.4 million (FY2022 interim: HK$627.5 million), owing partly to the suspension of business on 1 April 2022 to 20 April 2022 as well as the slower recovery in the first quarter when we resumed our business operation. Following the ease of pandemic, second quarter in Hong Kong marked a 52.1% growth in revenue quarter-on-quarter. As of 30 September 2022, the Group has a well established network of service centres in Hong Kong covering a total of 189,000 square feet. During the period, the Group has opened an additional service centre in Yuen Long to capture additional demand in the surrounding areas. With the gradual resumption of business in last few months, we witnessed a progressive improvement in customer spending and shop utilisation in the aesthetic medical business. Continual effort were made through the combination of online and offline marketing to reach out to existing and new customers.As for the medical business, our current scope comprises a range of complementary services including hair growth treatment, pain treatment, health screening service and others, which allows the Company to enjoy additional revenue stream from the existing customers through cross-selling and further reinforces the Group's image as a one-stop shop for your beauty and medical in Hong Kong.Regions outside Hong KongRevenue from regions outside Hong Kong increased by 1.0% to HK$175.9 million (FY2022 interim: HK$174.1 million), impacted substantially by the suspension of business in China and Macau but compensated by the encouraging performance in both Singapore and Australia. As of 30 September 2022, the Group has an extensive network in China, Macau, Sydney, Melbourne and Singapore, covering a gross service area of approximately 118,000 square feet.For the period under review, our business in China continued to record decent profit amid the difficult circumstance. Currently, the Group focuses on the first tier cities including Beijing, Shanghai, Guangzhou and Shenzhen to maintain superior branding in the industry. During the period, the Group has opened two shops in strategic locations in Guangzhou and Beijing to strengthen our presence. ProspectsDr. Au-Yeung Kong, the executive director, chairman and chief executive officer of Perfect Medical, said that "as a home-grown enterprise which has been established for more than 19 years, the Group is confident on the long term prospect of our aesthetic medical and medical service business model. In future, the Group will expand both organically and inorganically to offer additional and complementary services to our customers.While the pandemic fluctuation is going to be short-term, the Company will be cautiously expanding our geographical coverage and replicating our success in mainland China and overseas in the coming years, taking advantage on our efficient business model.Looking ahead, the Company will increase the proportion of medical services and proceed with its international business expansion, with a view to becoming a truly multinational medical group."For further information of the Group's FY2022/23 interim results, please refer to the Company's Interim Results Announcement on the Hong Kong Stock Exchange website at: https://www1.hkexnews.hk/listedco/listconews/sehk/2022/1123/2022112300240_c.pdfAbout Perfect Medical Health Management LimitedPerfect Medical Health Management Limited is a multinational aesthetic medical corporate and one of the largest aesthetic medical operators in the world established in 2003. The Group focuses primarily on non-invasive aesthetic medical services and medical services in Hong Kong, China, Macau, Australia and Singapore with a total service area spanning approximately 307,000 square feet. Our operation offers a broad spectrum of professional services with assurance of utmost safety and efficacy. The Company was included as a constituent stock of the MSCI Hong Kong Small Cap Index on 27 May 2021, demonstrating the confidence from the capital market and recognising the investment value of the Company. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

ACN Newswire

Asian Logistics, Maritime and Aviation Conference concludes

23 11 月, 2022

HONG KONG, Nov 23, 2022 - (ACN Newswire via SEAPRWire.com) - With a lengthy history as a global trading port, Hong Kong this week hosted the 6th edition of Hong Kong Maritime Week. The week's flagship event was the 12th Asian Logistics, Maritime and Aviation Conference (ALMAC), jointly organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), which came to a close today. This signature two-day event for the maritime, air freight, logistics and supply chain management sectors and shippers from diverse manufacturing industries drew more than 90 industry experts and leaders sharing insights at over 30 sessions. ALMAC this year attracted more than 14,000 online and physical participants from over 50 countries and regions.The 12th Asian Logistics, Maritime and Aviation Conference, jointly organised by the Government of HKSAR and HKTDC, concluded successfully today, attracting more than 14,000 physical and online participants from over 50 countries and regions.Daryl Tay, President, North Asia District of UPS Parcel Delivery Service, said RCEP opens up huge opportunities in Asia.Simon Bennett, Deputy Secretary General of International Chamber of Shipping, said fuel producers and shipowners needed incentives to invest in the uptake of new fuels.Themed "The Future of the Sustainable Supply Chain: Connectivity, Collaboration, Innovation", the hybrid-format conference attracted industry players from around the world who expanded business connections and explored partnership opportunities both face-to-face and virtually. Satellite conference venues across Mainland China, the wider Asian region, Australia and Europe also hosted physical events. In addition to relaying the conference from Hong Kong, some satellite venues invited experts to address logistics issues and share their experiences as well as join face-to-face exchanges and business matching activities.Collaboration on supply chain integration to create opportunitiesIn the first Power Dialogue session, industry leaders discussed how Regional Comprehensive Economic Partnership (RCEP) economies create opportunities by integrating regional trade and supply chains, and discussed strategic plans to capture opportunities. Daryl Tay, President, North Asia District of UPS Parcel Delivery Service, said RCEP opened huge opportunities in Asia. Regional collaboration was the key, so it was important to help SMEs understand the agreements and capitalise on RCEP opportunities.GBA, decarbonisation and sustainable developmentConnectivity is a major component of cooperation among the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) cities. The two maritime forums on day one brought together experts from maritime and technology sectors to examine Hong Kong's unique role as an international maritime hub. Speakers discussed shipping sustainability, decarbonisation and digitalisation through practical collaborative action and uncovered potential opportunities and benefits switching to sustainable and digitalised shipping. Simon Bennett, Deputy Secretary General of International Chamber of Shipping, said moves towards sustainable supply chains through measures, such as greener fuels, played a key role in supply chain optimisation. Limited time meant it was important that economic measures be developed at a global level because, despite positive progress, investors needed a prompt signal, while fuel producers and shipowners should have incentives to invest in new fuel uptake. Exhibitors showcase logistics solutionsComplementing the conference, an exhibition featured more than 50 stalls showcasing supply chain solutions and innovative logistics technologies to help SMEs enhance supply chain management. The HKTDC organised business matching meetings for participants and exhibitors to facilitate collaboration.Hong Kong Maritime Week flagship eventALMAC is the flagship event of Hong Kong Maritime Week, organised by the Hong Kong Maritime and Port Board. The sixth Hong Kong Maritime Week runs from 20 to 26 November to showcase the vibrant Hong Kong maritime industry and promote Hong Kong as a preferred base for maritime business.ALMAC: https://www.almac.hk/main/en/Photo download: https://bit.ly/3V2OPqyAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedIn.Media EnquiriesPlease contact Impact Communications Company:Cindy Chung, Tel: +852 9166 0827, Email: cindy.chung@impact-cc.comRaymond Lee, Tel: +852 6539 4089, Email: raymond.lee@impact-cc.comHKTDC's Communications & Public Affairs Department:Clayton Lauw, Tel: +852 2584 4472, Email: clayton.y.lauw@hktdc.orgClementine Cheung, Tel: +852 2584 4514, Email: clementine.hm.cheung@hktdc.orgSam Ho, Tel: +852 2584 4569, Email: sam.sy.ho@hktdc.org Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

完美医疗公布2022/23中期业绩

23 11 月, 2022

HONG KONG, Nov 23, 2022 - (亚太商讯 via SEAPRWire.com) - 全球最大的医疗美容营运商之一，完美医疗健康管理有限公司（「完美医疗」或「公司」；股票代码：1830.HK）连同其附属公司（统称「集团」）欣然宣布其截至2022年9月30日止的中期业绩。业绩亮点-- 本集团收益减少16.6%至668.3百万港元，此乃受到Covid-19疫情影响，香港业务暂停营运20天，澳门业务暂停营运39天，以乃广州、深圳、上海及北京业务分别平均停业14天、23天、63天及19天。-- 随着Covid-19疫情渐趋缓和，第二季度香港业务收益按季录得增长52.1%。-- 集团EBITDA下跌25.5%至229.7百万港元。-- 本集团录得纯利下跌30.4%至为150.7百万港元，纯利率为22.5%。每股基本盈利为12.1港仙。-- 董事会建议派付中期股息每股13.0港仙，派息比率为107.4%。-- 本集团于香港、中国、澳洲及新加坡营运面积合共307,000平方呎，并于期内在香港、广州及北京增设三间店铺。于回顾期内，本集团的表现受到香港消费趋势放缓及中国疫情反弹的影响。本集团的收益减少16.6%至668.3百万港元（二零二二财政年度中期：801.6百万港元）。在EBITDA水平方面，本集团下跌25.5%至229.7百万港元（二零二二财政年度中期：308.2百万港元）。本集团在业务扩张方面采取审慎态度，首重增强营运效率、业务流动性及适应能力，以便更好地保障本公司的资产及盈利能力。本公司权益持有人应占利润为150.7百万港元，按年下跌30.4%（二零二二财政年度中期：216.4百万港元），纯利率为22.5%（二零二二财政年度中期：27.0%）。每股基本盈利为12.1港仙（二零二二财政年度中期：17.7港仙）。截至二零二二年九月，本集团在香港、中国及海外营运面积合共307,000平方呎。香港业务来自香港业务的收益减少21.5%至492.4百万港元（二零二二财政年度中期：627.5百万港元），部分原因是于二零二二年四月一日至二零二二年四月二十日暂停业务，以及于我们恢复业务营运的第一季度复苏缓慢。随着疫情渐趋缓和，本集团第二季度香港业务收益按季增长52.1%。于二零二二年九月三十日，本集团于香港设有完善的服务中心网络，覆盖合共189,000平方呎。鉴于新界的需求日益增加，本集团于期内在元朗增设服务中心，藉以抓紧周边地区的额外需求。随着我们的业务于过去数月逐步恢复，我们见证医疗美容业务的顾客消费力及店铺利用率渐见起色。本集团继续致力透过结合在线及线下营销的方式，接触现有及新顾客。就医疗业务而言，我们目前的范围包括一系列互补服务，包括生发疗程、痛症治疗、健康检查服务及其他，让本公司可透过交叉销售从现有顾客获得额外的收益来源，并进一步巩固本集团作为香港一站式美容及医疗的形象。香港以外地区来自香港以外地区的收益增加1.0%至175.9百万港元（二零二二财政年度中期：174.1百万港元），主要受中国及澳门业务的停摆影响，惟由新加坡及澳洲录得令人鼓舞的表现所抵销。于二零二二年九月三十日，本集团的网络广泛，遍布中国、澳门、悉尼、墨尔本及新加坡，服务总面积约为118,000平方呎。于回顾期内，我们于中国的业务于期内在此艰难环境下继续录得可观利润。目前，本集团专注于北京、上海、广州及深圳等一线城市，以维护我们在业内的卓越品牌形象。诚如报告所述，本集团于期内在广州及北京的战略地点开设两间店铺，藉以扩大我们的业务覆盖范围。前景完美医疗执行董事、主席兼首席执行官欧阳江医生说：「作为一家成立超过19年的本土企业，本集团对医疗美容及医疗服务业务模式的长远前景充满信心。未来，本集团将投放更多资源于内部增长及外部并购，为顾客提供额外及互补服务。尽管疫情将于短期内反复波动，惟本公司于未来几年将审慎扩大业务的覆盖地域，并复制我们高效的业务模式，成功应用于中国内地及海外地区发展。展望未来，公司将增加医疗服务比重的同时，也会推进国际业务的发展，令公司进一步成为跨国医疗集团。」有关集团2022/23上半财年业绩的进一步信息，请参考公司在香港联交所网站的年度业绩公告：https://www1.hkexnews.hk/listedco/listconews/sehk/2022/1123/2022112300240_c.pdf 关于完美医疗健康管理有限公司完美医疗健康管理有限公司成立于2003年，是一家跨国医疗集团，是全球最大的医疗美容营运商之一。集团主要专注于无创医疗美容服务及医疗服务，现主要分布于香港、中国、澳门、澳洲和新加坡，服务总面积约为307,000平方呎。我们的专业服务涉及广泛，并保证最大的安全性和疗效。公司于2021年5月27日获纳入MSCI香港小型股指数，显示资本市场对本公司表现及投资价值的认可和肯定。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

力勤资源招股中：业绩强劲增长下游需求传导长期增长空间广阔

23 11 月, 2022

HONG KONG, Nov 23, 2022 - (亚太商讯 via SEAPRWire.com) - 随着全球电动汽车电池的市场规模逐步增长，作为动力电池重要原材料之一的镍，其需求端也迎来爆发，并带动相关企业成为市场关注热点。11月21日-11月24日，镍全产业链龙头宁波力勤资源科技股份有限公司（下称「力勤资源」或「公司」，股份代号：2245.HK）在港招股，预计于12月1日正式登陆港交所。中金公司、招银国际为联席保荐人。市场领先地位稳固竞争优势明显力勤资源是一家镍产品贸易及生产领域的领先公司。按2021年的镍产品贸易量计，公司在全球排名第一；按2021年的镍矿贸易量计，在中国排名第一。公司的镍矿贸易量在2019年、2020年及2021年均为中国第一，2021年的市场份额为26.8%。在镍产品生产领域，根据灼识咨询报告，力勤资源在印度尼西亚布局的HPAL项目是全球现金成本最低的镍钴化合物生产项目。该项目采取目前全球处理中低品位红土镍矿最先进的工艺——第三代HPAL工艺，并对其进行优化和调整，进一步提高了产能，降低了能耗和生产成本。通过在关键流程及工艺上的突破，力勤资源得以在运营效率及盈利能力方面取得先发优势。值得一提的是，力勤资源以镍资源整合为方向，加速向产业链中下游垂直延伸，完成了对镍产业链环节的垂直整合。通过涵盖镍资源的上游采购及贸易、供应链服务、镍产品生产、技术改进、工程设计连同产业园建设及运营，公司能够提供一站式解决方案，全面满足客户的需求，创造更大效益。锂电池高镍路线成风口需求旺盛助推业绩高增长在动力电池领域，由于三元电池的能量密度更高，真实续航里程更长，因而在近年来得到广泛应用。在三元电池中，高镍三元电池又因其具备更高的能量密度以及更具成本优势，预期将成为新能源汽车行业的主流选择。根据灼识咨询报告，2021年至2026年，全球新能源汽车产业中硫酸镍的需求量预计将以30.0%复合年增长率增长，并于2026年达到1,403.3千金属吨。对镍生产企业来说，伴随着下游需求中电池对硫酸镍的需求增速显著，红土镍矿湿法冶炼-湿法中间品-硫酸镍-电池的路径重要性逐步凸显。力勤资源的HPAL项目在镍化合物生产上具备技术优势和成本优势，且具备120,000金属吨镍钴化合物（包括14,250金属吨钴）的总年设计产能，有望助力其成为下游电池厂商重要的原料供货商，并增厚公司业绩。HPAL项目一期于2021年5月投产后对公司业绩提升显著。2021年及2022年上半年，力勤资源的收入分别为人民币4,088.3百万元及人民币9,978.3百万元，同比增长144.1%。同期公司净利润分别为人民币89.0百万元及人民币2,289.6百万元，同比增长超24倍。可以预见，在下游新能源电池对镍需求驱动下，力勤资源的增长空间正在打开。总体而言，力勤资源通过向上游镍矿与下游镍产品的全产业链布局，在拓宽公司营收来源的同时，有助于公司充分发挥产业链各环节的协同效应，增强公司的可持续发展能力和核心竞争力。未来，在镍资源需求保持稳定增长的预期加持下，力勤资源的长期发展值得期待。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

ACN Newswire

Vietnam – Hong Kong New Vision . New Opportunities – Smart Cities’ Leaders Forum Closes with Great Success

22 11 月, 2022

HONG KONG, Nov 22, 2022 - (ACN Newswire via SEAPRWire.com) - Supported by the Consulate General of Vietnam in Hong Kong, hosted by CT Group, and organized by New Media Foundation and Aliquantum Group, "Vietnam - Hong Kong: New Vision . New Opportunities - Smart Cities' Leaders" forum-cum-luncheon (the "forum") was successfully held at Island Shangri-La, Hong Kong this afternoon. The gathering of ministerial officials, business leaders and professionals from diverse industries at the forum discussed the booming business opportunities in and between Vietnam and Hong Kong. The forum featured a welcome speech made by Mr Wu Ting Yuk, Anthony, GBS, JP, Member of the Standing Committee of the CPPCC National Committee and Honourable Advisor, New Media Foundation, with him mentioning the changes Vietnam has undergone for the betterment of future and that this forum has given them a great chance to discuss tourism, culture and other business opportunities between Vietnam and Hong Kong. Followed by addresses from Mr Pham Binh Dam, Consulate-General of the S.R of Viet Nam in the Hong Kong SAR and also Professor Hu Shao Ming, Herman, SBS, JP, Deputy, the 12th/13th National People's Congress of the People's Republic of China and Chairman, Ryoden Development Ltd., expressing their appreciation of the forum's aim of promoting cooperation between Vietnam and Hong Kong. The aforementioned together with Mr Tran Kim Chung, Chairman of CT Group; Ms Tran Ghue Giao, Member of the Board of Directors of CT Group and CT Land; Academician, Dr Pham Khoi Nguyen, Senior advisor of CT Group; Dr Lam Kin Chung, Honorary Doctoral of Hanoi University; Mr Tse Hoi Ga, Edgar, Chief Operating Officer of CT Land; Professor Chiu Tsang Hok Wan, BBS, JP, Founding Chairman, Greater China Culture Global Association and Dr Ho Wai Fung, Vincent, Founder and Chairman, New Media Foundation, cut the ribbon to official mark the start of the forum. At the forum, Mr Tran Kim Chung made a presentation themed "Vietnam's New Vision . New Opportunities", during which he shared his insights on the potentials Vietnam has and his hope to promote in-depth trade exchanges among ASEAN countries. CT Group, one of the largest developers in Vietnam, has with foresights spent the last 30 years meticulously preparing to "shift and become a future technology dragon" and a comprehensive urban developer. Mr Tran Kim Chung stated: "CT Group will continue to build on its strengths and play a vital role in business cooperation, supporting the incredible development in both Hong Kong and Vietnam, plus aiding their connection with the international market."The panel discussion at the forum had Professor Hung Wai Man, Witman, JP, as moderator, and Mr Pong Po Lam, Paul and Professor Lam Pong Yuen, Howard, as guest speakers, sharing their inspiring insights under the theme "New Opportunities". The speakers highly rated Hong Kong's internationally-recognised, forward-looking financial regulatory environment and emphasised Vietnam's great development prospects, as well as the strive to push for new breakthroughs and stronger ties between the two sides.The forum closed with the remarks of Dr Ho Wai Fung, Vincent. He said: "On behalf of New Media Foundation, I give my heartfelt appreciation to all of our guests who are here today to share with us their valuable insights. I believe the forum has given us a guiding vision on achieving interconnection between Vietnam and Hong Kong and seeing that interconnection become yet more diverse and in-depth in the future." Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

ACN Newswire

The 12th Asian Logistics, Maritime and Aviation Conference Opens

22 11 月, 2022

HONG KONG, Nov 22, 2022 - (ACN Newswire via SEAPRWire.com) - The 12th edition of the Asian Logistics, Maritime and Aviation Conference (ALMAC), jointly organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and Hong Kong Trade Development Council (HKTDC), opened today at the Hong Kong Convention and Exhibition Centre (HKCEC) in person and online. This year's ALMAC is expected to attract over 14,000 viewers from over 50 countries and regions. At this annual signature event for the maritime, air freight, logistics and supply chain management sectors and shippers from different industries, more than 90 industry experts and leaders will share their insights at close to 30 sessions.Dr Peter Lam, HKTDC Chairman, said the disruption and delays caused by the pandemic in the past three years have highlighted an urgent need to assess how we can manage supply chains differently, so they are better equipped to withstand future challenges.The opening session was officiated by Paul Chan, Financial Secretary of the HKSAR.The 12th edition of the Asia Logistics, Maritime and Aviation Conference, jointly organised by HKTDC and Government of the Hong Kong Special Administrative Region, opened today at the Hong Kong Convention and Exhibition Centre (HKCEC) in a hybrid format.Dr Peter K N Lam, Chairman of the HKTDC welcomed international delegates to the conference, saying: "In the past year, economies have confronted a myriad of challenges, not least the pandemic, war, inflation and rising energy prices. No country or region, including Hong Kong, is immune to these developments. This attests to how connected our world is today. We may live on opposite sides of the world from each other, but the phenomenon of globalisation has, particularly over the last few decades, intertwined our fates ever closer. The logistics, maritime and aviation industries are a principal driver and guardian of our interconnectedness. In today's increasingly globalised world, they flourish most in an environment of stability. The resilience and sustainability of global supply chains guarantee their continued growth. The disruption and delays caused by the pandemic in the past three years have highlighted an urgent need to assess how we can manage supply chains differently, so they are better equipped to withstand future challenges."Paul Chan, Financial Secretary of the HKSAR, officiated at the online opening, saying: "There is clear and compelling direction in the National 14th Five-Year Plan and the development plan for the Greater Bay Area. Together, they confirm Hong Kong's future as both an international shipping centre and a premier international aviation hub. To achieve those goals, Hong Kong will continue to integrate into our country's overall economic development. We will fully embrace the boundless opportunities they present us, in logistics - and a great deal more. There is, strategic direction, too, in this year's theme: 'The Future of the Sustainable Supply Chain: Connectivity, Collaboration, Innovation.' It hammers home what we need to realise the future we want."International speakers analyse the latest trends in the global logistics, shipping and air freight industriesThis year's conference featured a wide range of panel discussions and forums with a strong line-up of speakers. Global industry leaders discussed international and regional collaboration, the development of the Guangdong-Hong Kong-Macao Greater Bay Area (GBA), the Regional Comprehensive Economic Partnership (RCEP), innovation and technology, and sustainable developments from a variety of perspectives.In the keynote address this morning, Xiangchen Zhang, Deputy-Director General of the World Trade Organization, examined how governments and businesses in the international arena may join forces to mitigate the impact of supply chain disruption."Challenges and opportunities are the two sides of the same coin. To address common challenges in global supply chains, we will rely on connectivity, collaboration and innovation," said Zhang.This was followed by the Plenary Session featuring global business leaders, including Mathieu Renard Biron, Managing Director of Global Freight Forwarding of Kerry Logistics, Ludovic Renou, CEO of CMA CGM China and Wilkie Wong, Chief Financial Officer of Esquel Group, who discussed how business evolution and supply chain transformation can steer business growth and achieve sustainable development amidst the current economic climate by building connectivity, fostering collaboration and driving innovation.Mathieu Renard Biron said: "Given all the disruptions of supply chain in the past two years, more opportunities will be coming from Asia while leading to the change of people's expectations and experiences." He added that collaborations and partnerships are needed to foster innovation. The use of AI machine learning technology, for example, is part of our new normal.Air Freight Forum: Hong Kong as an international aviation hub in the post-pandemic eraAs an international aviation hub, the Hong Kong International Airport (HKIA) is one of the busiest and most advanced airports in the world. The Air Freight Forum, co-organised with the Airport Authority Hong Kong, discussed HKIA's "Airport City" vision covering the third runway, express air cargo terminal expansion, the new premium logistics centre, staff training strategies and the synergy created by HKIA and airports in Mainland China.Maritime Forum: The Way forwardConnectivity is a major component of cooperation among GBA cities. In the first of two Maritime Forums on day one, leaders from the maritime and technology sectors examined Hong Kong's role as an international maritime hub in the GBA. Industry experts engaged in conversation on shipping sustainability, decarbonisation and digitalisation in the second Forum.The Power Dialogue, titled "Asia for Asia - Powering the Growth of Supply Chain Networks", featured Kian Chuan Chang, Regional Director of Customs Brokerage & Trade Compliance of GEODIS APAC (Holdings), Wingco Lo, Executive Vice President of The Chinese Manufacturers' Association of Hong Kong, Daryl Tay, President, North Asia District of UPS Parcel Delivery Service and Eva Tsang, Assistant Vice President and Executive Director Opal Cosmetics Group. They looked at how RCEP creates opportunities through the integration of regional trade and supply chains and shared their strategic plans for capturing future opportunities.In the Thematic Session, Terence Chiu, Commissioner of the Hong Kong Export Credit Insurance Corporation, together with Ivy Tse, Co-Chief Executive Officer and Co-Founder of FreightAmigo, shared how businesses can capture opportunities created by supply chain integration in the GBA. This session provided practical insights and solutions for SMEs looking for expansion into the GBA.Tech experts at InnoTalks underscored game-changing innovative solutions and technologies that are driving advancements in modern logistics and smart supply chain development, helping companies to stay ahead of shifting consumer demands and expectations.Asian Logistics, Maritime and Aviation Exhibition: Connecting logistics technology and solution providers with shippersOver 50 exhibitors showcased their latest logistics and supply chain solutions, and innovative technologies to help SMEs enhance their global supply chain management. The HKTDC also arranged business matching sessions for participants to drive more business cooperation.In addition to the main physical event in Hong Kong, the HKTDC organised ALMAC satellite conferences in Chengdu, Fuzhou, Wuhan, Taiwan, Budapest, Edinburgh, Hamburg, Milan, Paris, Sydney and Warsaw. In addition to running a live broadcast of the Conference, some experts participated in selected satellite venues to address logistics issues and shared experiences from a local perspective.Shipper's Forum shares latest fulfilment trendsThe newly introduced Shippers' Forum, titled "E-commerce Fulfillment in Asia", will be held tomorrow (23 November) with Jenny Hui, General Manager of eBay Hong Kong, Taiwan and Global Emerging Markets sharing latest fulfilment trends and best practices for delivering reliable and agile fulfilment solutions.In the Power Dialogue on the same day, Pippo Au, Head of Supply Chain of Maxim's Group and Suzanne Cheung, Head of Public Affairs, Communications and Sustainability of Swire Coca-Cola Hong Kong, will highlight how companies are marching towards a sustainable supply chain.In the Closing Session, Chee Choong Ng, Senior Vice President & Managing Director Hong Kong & Macau, DHL Express (Hong Kong), Fox Chu, Partner of McKinsey, John Parkes, Managing Director - Integrated Logistics of Kerry Logistics and Graziano Terenzi, CEO of Inglobe Technologies, will discuss the metaverse and how the logistics industry can make use of robotics, extended reality, augmented reality and other technologies to drive industry development.Flagship event of Hong Kong Maritime WeekALMAC is Hong Kong Maritime Week's flagship event and is organised by the Hong Kong Maritime and Port Board and supported by the Hong Kong Logistics Development Council.ALMAC: https://www.almac.hk/main/en/ALMAC programme: https://almac.hktdc.com/conference/almac/en/programmeALMAC speaker list: https://almac.hktdc.com/conference/almac/en/speakerPhoto download: https://bit.ly/3TZdIC6About HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedIn.Media EnquiriesPlease contact Impact Communications Company:Cindy Chung, Tel: +852 9166 0827, Email: cindy.chung@impact-cc.comRaymond Lee, Tel: +852 6539 4089, Email: raymond.lee@impact-cc.comHKTDC's Communications & Public Affairs Department:Clayton Lauw, Tel: +852 2584 4472, Email: clayton.y.lauw@hktdc.orgClementine Cheung, Tel: +852 2584 4514, Email: clementine.hm.cheung@hktdc.orgSam Ho, Tel: +852 2584 4569, Email: sam.sy.ho@hktdc.org Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

力勤资源开启招股上半年净利润同比增长近25倍

22 11 月, 2022

HONG KONG, Nov 22, 2022 - (亚太商讯 via SEAPRWire.com) - 10月以来，港股IPO市场有所回暖，近期上市的11只新股中，仅1只首日破发。市场复苏之际，又一只优质新股进入招股期。11月21日，全球最大的镍产品贸易商宁波力勤资源科技股份有限公司（下称「力勤资源」，股份代号：2245.HK）在港开启招股，招股价介乎15.60港元至19.96港元之间，每手200股，预期于12月1日登陆港交所。根据招股书，力勤资源是一家全球领先的镍全产业链公司，同时进行镍产品的贸易及生产业务。按2021年的镍产品贸易量计，公司是全球最大的镍产品贸易商；按2021年的镍矿贸易量计，是中国最大的镍矿企业。业务覆盖镍全产业链持续强化竞争优势力勤资源深耕镍产业链多年，凭借多年积累的深厚行业认知，形成全面的产品服务体系，业务涵盖上游镍资源采购、镍产品贸易、冶炼生产、设备制造与销售等在内的多个产业环节。与此同时，公司还不断向镍行业上下游延伸，完成了对镍产业链环节的垂直整合，产品广泛地应用于新能源汽车、不锈钢行业等下游领域。在上游，力勤资源建立了稳固的供应渠道，能够带来持续稳定的镍资源供应，为公司长远健康发展及业务拓展提供了重要基础。在中游，有序优化生产流程和工艺，改进生产技术。例如，在镍产品生产领域，该公司与印度尼西亚合作伙伴合作开发的HPAL项目是全球技术最先进的镍钴化合物湿法冶炼项目之一，大幅降低了镍产品生产成本，显著提升了公司的盈利水平。2022年上半年，力勤资源毛利率达到30.9%，较去年同期的8.6%大幅提高了22.3个百分点。在下游，力勤资源与国内领先的三元电池材料生产商、大型钢铁集团建立了长期的战略合作关系，并不断向下游产业价值链延伸，特别是快速增长的新能源电池材料领域，既提升了其在下游市场的供应能力，也进一步提高了公司的综合实力和盈利能力。业绩强劲增长行业高需求下加速成长可期依托全产业链的生态布局，力勤资源得以逐步深化其在镍产品相关领域的布局，强化在供应链重点环节的竞争优势，从而推动业绩强劲增长。2020年、2021年以及2021年及2022年上半年，力勤资源的收入分别为人民币7,755.2百万元、人民币12,449.3百万元、人民币4,088.3百万元及人民币9,978.3百万元，同比分别增长60.5%以及144.1%。同期公司净利润分别为人民币518.3百万元、人民币1,260.0百万元、人民币89.0百万元及人民币2,289.6百万元，同比分别增长143.1%以及2472.6%，呈现出优异的成长性。行业方面，受益于电动汽车市场发展以及不锈钢消耗量的增加，全球镍需求量快速增长。根据灼识咨询报告，预计到2026年全球镍消耗量达4,789.0千金属吨，2021年至2026年的复合年增长率为10.6%。其中，由锂电池带动的全球镍消耗量的复合增长率高达32.2%，因此，镍产业景气度将维持高企。力勤资源作为市场上少有的业务覆盖镍全产业链的优质企业，具备很强的稀缺性。且其能够向市场长期提供低成本的镍资源以及高性价比镍产品，核心竞争力突出。未来，公司有望借着行业发展东风，迎来加速成长，全方面释放其投资价值。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

力勤资源正在招股深度布局镍全产业链高成长性引人瞩目

22 11 月, 2022

HONG KONG, Nov 22, 2022 - (亚太商讯 via SEAPRWire.com) - 在国内持续推进双碳目标浪潮下，新能源汽车市场迎来提速发展时期，高镍三元电池亦同步开启发展「新纪元」，提早进军镍产业的企业站上新能源汽车发展风口，成为了市场「宠儿」。11月21日，宁波力勤资源科技股份有限公司（「力勤资源」或「公司」；股份代码：2245.HK）开启招股，现在招股进行中，中金公司、招银国际为联席保荐人。招股书数据显示，力勤资源是一家镍全产业链公司，同时进行镍产品的贸易及生产业务。镍产品贸易领域，按2021年的镍产品贸易量计，力勤资源在全球排名第一，按2021年的镍矿贸易量计，公司在中国排名第一；镍产品生产领域，公司与印度尼西亚合作伙伴在印度尼西亚奥比岛合作开发的HPAL项目是全球技术最先进的镍钴化合物湿法冶炼项目之一，也是全球现金成本最低的镍钴化合物生产项目。构建完整镍产业生态系统掘金新能源车市场伴随着绿色低碳经济的转型，我国新能源汽车市场具备了高速增长基础，未来景气度将居高不下。中汽协最新数据显示，在9月产销双双突破70万辆大关后，10月新能源汽车产销再创历史新高，新能源汽车产销量分别达76.2万辆和71.4万辆，同比增长87.6%和81.7%，市场占有率达28.5%。对此，力勤资源顺势而为，掘金新能源汽车市场，构建了完整的镍产业生态系统。上游镍资源采购与贸易方面，在全球镍矿及镍铁主要出口国菲律宾和印度尼西亚建立了稳固的上游供应渠道，为其业务拓展奠定了坚实基础；冶炼生产、设备制造与销售方面，在中国及印度尼西亚均布局了自有生产基地可生产镍钴化合物以满足下游三元电池材料厂商的需求，也可生产镍铁应用于不锈钢等终端市场。下游镍产业价值链的延伸方面，力勤资源同国内领先的三元电池材料生产商和大型钢铁集团建立了长期的战略合作，亦计划将镍产业链延伸至新能源汽车电池及不锈钢炼钢领域。至此，公司打通了从镍资源开采到镍产品销售的全产业链环节，挖深了竞争护城河，从而开辟业绩强劲增长曲线，跨向公司发展史上的新里程碑。管理团队远见卓识业务规模迎来大爆发企业的长足发展离不开经验丰富、远见卓识的管理层团队，力勤资源的行稳致远亦得益于此。据了解，公司的管理团队在镍行业具有丰富的从业经验和行业洞察，具备合理预判市场波动、敏锐把握市场机会、高效执行应对战略的能力，可助力公司成为行业领导者。例如，公司董事会主席兼创始人蔡建勇先生在国际商品贸易领域拥有十余年经验、总经理江新芳先生在金属相关生产行业亦深耕十余年。凭借强劲的综合竞争实力，力勤资源业绩迎来爆发性增长，潜力逐步释放。招股书披露，2022年上半年，公司营业收入为99.78亿元，同比增长约144.07%，净利润达22.90亿元。毛利率由截至2021年6月30日止六个月的8.6%增加至2022年同期的30.9%，盈利能力强劲。高成长的业绩表现、镍资源消耗长期增加的产业预期加持，为力勤资源的成长性增添了许多确定性。面向未来，赴港IPO将令力勤资源成为港股镍全产业链布局的稀缺资产，资本市场的加持也将有利于公司进一步发挥自身综合优势，提升研发能力，扩大上游资源渠道，同时把握下游行业增长机遇，构建更为繁荣的镍资源生态系统，从而助推我国镍行业健康、可持续发展。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

力勤资源启动招股：业绩强劲增长全产业链布局彰显核心竞争力

22 11 月, 2022

HONG KONG, Nov 22, 2022 - (亚太商讯 via SEAPRWire.com) - 11月21日，宁波力勤资源科技股份有限公司（「力勤资源」或「公司」，股份代号：2245.HK）正式启动港股招股，拟全球发行232,547,600股股份，最高发售价为每股19.96港元。本次IPO由中金公司与招银国际联席保荐。据悉，力勤资源是一家镍全产业链公司，同时进行镍产品的贸易及生产业务。在镍产品贸易领域，按2021年的镍产品贸易量计，公司在全球排名第一；按2021年的镍矿贸易量计，公司在中国排名第一，2021年的市场份额为26.8%。深耕镍矿及镍铁贸易领域多年具备全产业链布局能力力勤资源在镍矿及镍铁贸易领域深耕多年，积累了行业知识并具备了全球化的前瞻性布局能力，不断地向上下游延伸，完成了对镍产业链的垂直整合，业务涵盖镍矿及镍铁贸易、冶炼生产、设备制造、销售等环节。在上游镍资源采购与贸易方面，力勤资源在全球镍矿及镍铁主要出口国菲律宾和印度尼西亚建立了稳固的上游供应渠道，与亚洲镍业（Nickel Asia Corporation）及CTP Construction and Mining Corp.等菲律宾领先的镍矿开采商均建立了长期且稳定的合作关系，使公司的镍矿资源得到长期稳定的供应。根据灼识咨询报告，于2019年、2020年及2021年，公司在菲律宾的镍矿出口量均为全球第一，2021年的市场份额为28.2%，为其业务拓展打下了牢固的根基。在冶炼生产、设备制造与销售方面，力勤资源高度重视对现有生产流程和工艺的优化以及对先进技术的探索，在中国及印度尼西亚均布局了自有生产基地，有效对接上下游资源。力勤资源与印度尼西亚合作伙伴在印度尼西亚奥比岛合作开发的HPAL项目主要用于生产MHP，未来亦将能够生产硫酸镍、硫酸钴等镍钴化合物。目前，HPAL项目一期已于2021年投产，根据灼识咨询报告，在镍产品生产领域，HPAL项目是全球技术最先进的镍钴化合物湿法冶炼项目之一，也是全球现金成本最低的镍钴化合物生产项目。在下游镍产业价值链的延伸方面，力勤资源的镍钴化合物产品被广泛地用作新能源汽车三元电池的核心原材料。HPAL项目一期两条生产线的达产，使公司在印度尼西亚布局镍湿法冶炼项目的中国公司之中占据了先发优势。同时，HPAL项目的终端市场新能源汽车产业的快速增长，亦使得HPAL项目生产的镍钴化合物产品具有较强的市场需求及稀缺性。此外，力勤资源的镍矿及镍铁产品主要应用于不锈钢等终端市场，公司计划将镍产业链进一步延伸至新能源汽车电池及不锈钢炼钢领域。客源稳定财务数据靓丽新一轮腾飞指日可待凭借多年来对镍产业链的参与，力勤资源积累了良好的信誉和口碑，与众多客户建立了长期的战略合作关系，包括国内领先的三元电池材料生产商和大型钢铁集团，使公司能够受益于下游领域强劲增长，不断延伸下游产业价值链。财务方面，近年来力勤资源的业绩实现了强劲增长。于2020年、2021年以及截至2021年及2022年6月30日止六个月，公司的收入分别为人民币7,755.2百万元、12,449.3百万元、4,088.3百万元及9,978.3百万元，而净利润分别为人民币518.3百万元、1,260.0百万元、89.0百万元及2,289.6百万元，显示出2021年度、2022年上半年的收入和净利润同比均大幅提升。从行业角度来看，近年来全球及中国的镍消耗量持续增长。根据灼识咨询报告，全球镍年消耗量于2021年至2026年的复合年增长率预计将达10.6%。中国镍年消费量于2021年至2026年的复合年增长率预计将达11.2%，于2026年占全球镍消费量的比例将达51.3%，发展前景十分广阔。依托多年的行业认知积累，力勤资源搭建起不同路径的产品组合、全产业链布局及优质客户群体，伴随IPO的顺利推进，正逐步增强在全球镍行业的领先地位并扩展及深化在产业链的业务，进而实现新的一轮腾飞。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

ACN Newswire

Keen Interest from Thai Business Community to Collaborate with Hong Kong on New Opportunities

21 11 月, 2022

HONG KONG, Nov 21, 2022 - (ACN Newswire via SEAPRWire.com) - More than 200 Thai business leaders today joined a lunch seminar organised by the Hong Kong Trade Development Council (HKTDC) in Bangkok, affirming the Thai business community's confidence in Hong Kong's role to help businesses in the region grow and tap into opportunities in Hong Kong and Mainland China.The luncheon seminar was held today with the theme "Hong Kong-Thailand: Enterting a New Era of Opportunities". HKTDC Chairman Dr Peter K N Lam giving opening remarks.Supattanapong Punmeechaow, Deputy Prime Minister and Minister of Energy of the Kingdom of Thailand delivered remarks.Hong Kong business delegation led my HKSAR Chief Executive, John Lee, meets with the Ambassador Extraordinary and Plenipotentiary of the People's Republic of China to the Kingdom of Thailand, Han Zhiqiang, in Bangkok on 20 November.The seminar was organised as a key closing event of a high-level business mission to Bangkok, led by the Chief Executive of the Hong Kong Special Administrative Region (HKSAR), Mr John Lee, and supported by the HKTDC.Despite the pandemic, the Thai business community has shown keen interest in using Hong Kong as a springboard for their business expansion, fundraising and investment partnerships.The business mission wrapped up a three-day programme of meetings and networking with leading Thai businesses to update them on the latest prospects in Hong Kong, including the city's strategic investment in innovation and technology, the latest overseas talent and enterprise attraction measures. There were also fruitful exchanges about opportunities in the Guangdong-Hong Kong-Macau Greater Bay Area and the development of the Northern Metropolis in Hong Kong.HKTDC Chairman Dr Peter K N Lam said, "From this exchange, we can see that Thai businesses have full confidence in Hong Kong. They have keen interest in regards to, in particular, Hong Kong's role as an international financial centre and a springboard to the Guangdong-Hong Kong-Macau Greater Bay Area. Following the resumption of international travel connecting Hong Kong, we hope this mission will help Hong Kong businesses find more opportunities in Thailand and ASEAN."The HKTDC is planning a large-scale "Think Business, Think Hong Kong" business promotion campaign in Thailand in July next year, to showcase Hong Kong as a hub for connecting global businesses as well as Hong Kong products and services to the Thai business community. More Thai business are expected to join.Through its worldwide network of 50 offices, the HKTDC continues to engage in overseas outreach through business missions and local events and activities. Photo Download: https://bit.ly/3TUnvJTAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedIn.Media enquiriesPlease contact the HKTDC's Communications and Public Affairs Department:Agnes Wat, Tel: +852 2584 4554, Email: agnes.ky.wat@hktdc.org Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

ACN Newswire

布局全球，深入欧洲，新光维医疗MEDICA 2022展会圆满结束

21 11 月, 2022

HONG KONG, Nov 21, 2022 - (亚太商讯 via SEAPRWire.com) - 2022年11月18日，第54届国际医院及医疗设备博览会（MEDICA）在德国杜塞尔多夫展览中心圆满结束。作为公认的世界上最大、最专业的医院及医疗设备展览会，MEDICA以不可取代的规模和影响力吸引着来自约70个国家和地区的4400多家公司参展。新光维医疗携自主研发的一次性使用电子内窥镜解决方案及医用内窥镜成像系统亮相MEDICA 2022，并宣布了与富士胶片欧洲的战略合作。协议约定，富士胶片欧洲作为独家分销商，负责新光维医疗一次性使用电子支气管镜在欧洲一些主要国家的销售和业务拓展。新光维医疗MEDICA 2022展台现场新光维医疗一次性使用内窥镜系列产品在MEDICA 2022展出新光维医疗4K超高清、4K荧光医用内窥镜系统以及3D图像处理系统在MEDICA 2022展出新光维医疗MEDICA 2022 展台现场：医用内窥镜成像系统新光维医疗MEDICA 2022展台现场新光维医疗是一家以“立足中国，放眼世界”为核心发展战略的微创诊疗企业，在中国和日本都设有研发中心，“研发全球化”是新光维医疗全球化布局的核心策略。此次在MEDICA展出的产品研发都是基于和中国和日本两大研发中心的协作开发。此外，新光维医疗自成立以来也一直实施“知识产权全球化”，其多款产品已同时获得FDA、CE、PDMA注册认证，专利布局包含海内外。在中国企业从制造能力的输出向商业实践和思想的输出的演变过程中，新光维医疗紧跟步伐，全面实施“营销全球化”。目前，新光维医疗已在欧洲、北美、日本等海外发达市场进行商业化布局，积极参加各类国际医疗器械大会展览。新光维医疗借助此次MEDICA，将进一步深入欧洲医疗器械市场，展示公司全面的产品布局及创新的技术实力，不断推进其一次性使用内窥镜解决方案及医用内窥镜成像系统在德国、法国、意大利、西班牙、英国等欧洲主要国家的落地商业化。创新医疗技术新光维医疗重视产学研合作和医工结合，长期与许多医院和知名临床专家交流合作。新光维医疗以“全球化”为核心战略，希望为世界各地的医院和医生提供创新且符合临床需求的产品。基于产品的卓越品质，以及强大的临床支持和产业合作网络，新光维医疗已经取得了许多成就。例如，本月，新光维医疗与上海市第一妇婴保健院签署战略合作协议，共同建立妇科内镜诊疗联合创新中心。基于强大的自研能力，新光维医疗现已构建起了以五大核心技术（超高清医用内窥镜成像技术、特殊光医用城乡技术、超细内镜成像技术、一次性使用内窥镜技术、3D医用成像技术）为基础的独有技术平台，全面的产品及在研产品组合以覆盖各类临床科室。新光维医疗的产品涵盖软性内窥镜和硬性内窥镜，以及一次性使用医用内窥镜和重复使用医用内窥镜。凭借其领先的技术，新光维医疗的产品在医用内窥镜领域具有独特的优势。例如，新光维医疗是全球唯一一家同时获得FDA批准的4K超高清成像系统和4K超高清内窥镜的公司。MEDICA 2022：布局全球，深入欧洲新光维医疗在杜塞尔多夫举办的MEDICA展会亮相，展示了其3D内窥镜成像系统、4K 超高清内窥镜成像系统、4K 超高清荧光成像系统以及一次性使用电子医用内窥镜系列等创新产品。这些产品对于疾病的临床诊断具有重要价值。“对新光维医疗来说，我们始终将重点放在患者身上，我们希望能为患者提供最好的诊断及治疗手段。在此次展会中，我们让来参观的观众认可了新光维医疗的产品质量。因此，对我们来说，这次MEDICA取得了圆满成功。”新光维医疗海外营销副总裁李惠成先生表示。“此外，在此次展会中，我们还了解到很多竞争对手的产品进展。尽管竞争激烈，但我们确信，因为新光维医疗产品质量的卓越表现，未来几年，我们将在欧洲医疗器械市场发挥决定性的作用。”关于新光维医疗新光维医疗成立于2016年10月，是一家专注于医用内窥镜及相关创新产品的研发及商业化的微创诊疗企业。公司以“立足中国，放眼全球”作为核心发展战略，在中国和日本均已成立研发中心。依托于强大的自主研发能力，新光维医疗已建立立足于五大相互协同的核心技术之上的独有技术平台，并打造了全面的医用内窥镜产品及在研产品组合，覆盖医院各类临床科室进行的全部类型内窥镜手术，以满足多样化的医疗需求。秉承“聚焦临床”“协作创新”“以人为本”“卓越高效”的企业价值观，新光维医疗将持续升级微创诊疗核心技术，通过优秀的产品力提高市场渗透率，成为全球医生和患者信赖的首选品牌。欲了解更多信息请浏览公司网站：www.scivitamedical.com媒体垂询：新光维医疗王婷PR电子邮件：tingwang@scivitamedical.com 电话：(86-512) 8187 7788-8012 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

ACN Newswire

国轩高科与VinES合作越南首个LFP电池工厂开工

21 11 月, 2022

HONG KONG, Nov 21, 2022 - (亚太商讯 via SEAPRWire.com) - 11月18日，国轩高科与越南VinGroup合作的电池工厂在越南河静经济开发区正式开工。该项目一期规划年产能5GWh，是越南第一个磷酸铁锂电池工厂，预计2023年末投产。河静省省委书记黄中勇先生，省委常务副书记陈世勇，省人委会主席武仲海先生，VinGroup 集团副董事长兼总经理阮越光先生，国轩高科董事长李缜先生，VinES公司总经理范垂玲女士等共同见证了本次仪式。开工仪式现场本次开工的越南VinES-Gotion河静电池工厂，由国轩高科及越南VinGroup集团旗下VinES共同投资，其中国轩高科持股51%，VinES持股49%，是越南首个磷酸铁锂电池制造工厂。据规划，工厂占地210亩，项目规划年产能5GWh，预计2023年底完成建设并投产。未来，该工厂的产品将满足越南VinFast 新能源汽车对电池的需求。越南VinES隶属于越南最大民营企业VinGroup集团，主要负责动力电池生产业务。该集团旗下VinFast系全球领先的新能源汽车制造企业，产品在东南亚市场广受赞誉，并远销欧美。仪式现场，VinES公司总经理范垂玲表示，VinES非常荣幸与Gotion合资建设的LFP电池工厂，这是VinFast电动汽车自主电池供应战略的重要组成部分，也是VinES领先的能源解决方案公司发展战略的一部分。新工厂位于VinES电池组生产厂旁，将完成越南LFP电池的闭环生产，从而提高VinFast电动汽车的本地化率和生产效率，同时为越南电动汽车和清洁能源产业发展开辟新的机遇。国轩高科董事长李缜表示， VinGroup集团是全球备受尊敬的企业，国轩高科与VinGroup合作的电池工厂，将支持VinFast的电动汽车对电池的需求，不仅助力越南的能源变革、气候友好和经济发展，也将共同为人类社会的能源文明做出贡献。今年以来，国轩高科全球化战略逐步落地，6月与阿根廷JEMSE公司达成战略合作，拟合资在阿根廷胡胡伊省建立电池级碳酸锂产线；同期德国国轩正式揭牌，开启国轩电池“欧洲造”步伐；7月，公司通用存托凭证（GDR）在瑞士交易所敲钟上市；9月与苏美达签订战略合作协议，推动储能产品出口业务发展。据公司规划，到2025年有望实现全球300GWh产能，其中海外100GWh，助力全球碳中和实现。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

「空中丝绸之路」国际合作论坛成功举办中卢企业合作成果颇丰

18 11 月, 2022

HONG KONG, Nov 18, 2022 - (亚太商讯 via SEAPRWire.com) - 据财华社报道，今年以来，全球多国放宽入境限制，航空业逐步复苏；而近期我国亦取消了入境航班熔断机制，预计航空业将在人员往来、货物运输等方面发挥更大作用。早在2017年，郑州—卢森堡「空中丝绸之路」的构想便首次提出，今年中央再发《「十四五」时期推进「空中丝绸之路」建设高质量发展实施方案》推动合作深化，值此机遇期，郑州—卢森堡「空中丝绸之路」国际合作论坛于11月16日成功举办。据悉，本次论坛以「在线+线下」形式举办，吸引了多位中外重要嘉宾参与，带来诸多独到见解。中央政治局委员、国家发展改革委主任何立峰表示：「今年是中卢两国领导人提出建设郑州－卢森堡『空中丝绸之路』5周年，也是两国建交50周年，论坛的举办对于落实好中卢两国领导人重要共识具有重要意义。」卢森堡首相格扎维埃·贝泰尔亦表示：「卢森堡与中国的关系是我们与欧洲以外国家建立的最具活力的关系，双方建立了不断发展的牢固友谊，卢森堡愿在『空中丝绸之路』框架下，为中国贸易和服务业的发展作出更多贡献。」本次论坛上，多家中卢企业进行签约，据统计有9个合作项目进行了现场签约，14个合作项目进行了云签约，将「空中丝路」的合作落到实处。其中，河南民航发展投资集团（河南航投）与卢森堡国际银行（BIL）签署战略合作协议，双方将在国际金融、绿色金融及境外绿色债权发行等方面进行全方位的探索和合作。此外，河南航投亦特邀BIL为该集团金融咨询顾问，为其提供欧洲宏观经济分析、金融市场动态等信息信息及金融领域的专业建议。在线出席论坛的卢森堡国际银行CEO马塞尔·莱尔斯首先祝贺了中国与卢森堡大公国建交50周年，指出不断加深的联系为两国商业机构提供了巨大业务增长空间。对于本次与河南航投的战略合作，他表示：「这是我行主要股东联想控股帮助银行与中资客户发展业务，促进中欧经济往来的又一力证。我非常期待双方未来的合作，并诚挚感谢为此付出努力的各位同仁。作为卢森堡历史最悠久的银行，BIL一直致力于在开展业务的国家和地区，支持当地经济和社会发展。」联想控股CEO李蓬表示，「祝贺卢森堡国际银行与河南航投集团签订战略合作协议，进一步为『空中丝路』的建设，为中欧经贸合作和绿色金融合作，做出更多贡献。作为卢森堡国际银行的主要股东，联想控股将继续提供各项支持，为推动共建『一带一路』高质量发展，推进高水平对外开放，不断贡献力量。」联想控股于2018年完成对卢森堡国际银行的战略投资，借助卢森堡作为欧洲门户的特殊地位，该银行在促进中卢、中欧合作中发挥着独特价值，本次「空中丝路」中的战略合作可谓又一次体现。相信未来，卢森堡国际银行将继续为「中国企业走进欧洲、欧洲公司到中国来」的双边经济合作创造更多价值。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

1 …6 7 8 9 10 … 25